Skip to main content
Premium Trial:

Request an Annual Quote

StoneCalibre Buys DNA Sequencing Consumables Firm Edge Biosystems

NEW YORK (GenomeWeb) – Private investment fund StoneCalibre today announced the acquisition of DNA sequencing consumables firm Edge Biosystems for an undisclosed amount.

Based in Gaithersburg, Md., EdgeBio manufactures and distributes sample preparation and clean-up products for DNA sequencing. Its products are used in clinical and diagnostic laboratories, food testing, molecular medicine, ancestry studies, and other applications. The company was founded in 1990.

Last year, EdgeBio sold its next-generation sequencing service business to GeneDx, while it retained its product business, which includes reagents for sequencing clean up, PCR purification, sample prep, and competent cells for cloning applications.

"We believe EdgeBio will continue to build on its tradition of providing high-quality, easy-to-use products to its global customer base and serve as a strong platform for future growth," StoneCalibre Founder and CEO Brian Wall said in a statement.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.